Roche Holding AG (FRA:RHO5)
Germany · Delayed Price · Currency is EUR 356.25
-0.60 (-0.17%)
Inactive · Last trade price on Mar 16, 2026
Roche Holding AG Financials Overview
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 63,356 | 63,356 | 62,395 | 60,441 | 65,814 | 65,850 |
Revenue Growth | -0.21% | 1.54% | 3.23% | -8.16% | -0.06% | 9.13% |
Gross Profit Gross Profit Growth | 47,194 | 47,194 | 46,664 | 44,844 | 47,876 | 46,490 |
Operating Income Operating Income Growth | 20,958 | 20,958 | 19,617 | 17,779 | 20,569 | 20,253 |
Net Income Net Income Growth | 12,880 | 12,880 | 8,277 | 11,498 | 12,421 | 13,930 |
Earnings Per Share EPS Growth | 16.04 | 16.04 | 10.31 | 14.31 | 15.37 | 16.20 |
EPS Growth | 36.58% | 55.58% | -27.95% | -6.90% | -5.10% | -1.99% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceuticals - Roche Pharmaceuticals Pharmaceuticals - Roche Pharmaceuticals Growth | 36,838 | 48,068 | 46,341 | 44,064 | 45,743 | 45,709 |
Pharmaceuticals - Chugai Pharmaceuticals - Chugai Growth | 3,990 | 7,024 | 6,882 | 7,203 | 9,270 | 8,358 |
Diagnostics Diagnostics Growth | 10,906 | 13,964 | 14,464 | 14,654 | 17,798 | 17,860 |
Elimination Elimination Growth | - | -5,700 | -5,292 | -5,480 | -6,997 | -6,077 |
Total Total Growth | 49,866 | 63,356 | 62,395 | 60,441 | 65,814 | 65,850 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 15,486 | 15,486 | 17,333 | 10,511 | 9,767 | 13,033 |
Total Debt Total Debt Growth | 33,197 | 33,197 | 36,379 | 30,850 | 26,699 | 32,572 |
Net Cash (Debt) Net Cash Growth | -17,711 | -17,711 | -19,046 | -20,339 | -16,932 | -19,539 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -22.06 | -22.06 | -23.75 | -25.30 | -20.96 | -22.72 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 18,852 | 18,852 | 20,094 | 16,095 | 17,803 | 20,976 |
Capital Expenditures CapEx Growth | -3,748 | -3,748 | -3,529 | -3,742 | -3,449 | -3,693 |
Free Cash Flow Free Cash Flow Growth | 15,104 | 15,104 | 16,565 | 12,353 | 14,354 | 17,283 |
Free Cash Flow Growth | -4.38% | -8.82% | 34.10% | -13.94% | -16.95% | 14.93% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 74.49% | 74.49% | 74.79% | 74.19% | 72.74% | 70.60% |
Operating Margin | 33.08% | 33.08% | 31.44% | 29.42% | 31.25% | 30.76% |
Pretax Margin | 26.79% | 26.79% | 18.90% | 23.29% | 24.81% | 26.42% |
Profit Margin | 20.33% | 20.33% | 13.26% | 19.02% | 18.87% | 21.15% |
FCF Margin | 23.84% | 23.84% | 26.55% | 20.44% | 21.81% | 26.25% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 10.855 | 9.800 | 9.700 | 9.600 | 9.500 | 9.300 |
Dividend Per Share Growth | 6.61% | 1.03% | 1.04% | 1.05% | 2.15% | 2.20% |
Dividend Yield | 3.06% | 3.07% | - | - | - | 4.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.55 | 20.35 | 24.79 | 17.14 | 19.31 | 22.03 |
P/FCF Ratio | 17.53 | 17.35 | 12.39 | 15.95 | 16.71 | 17.75 |
PS Ratio | 4.18 | 4.14 | 3.29 | 3.26 | 3.64 | 4.66 |